Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Modulation of mitochondria in the axon and soma of retinal ganglion cells in a rat glaucoma model.

Munemasa Y, Kitaoka Y, Kuribayashi J, Ueno S.

J Neurochem. 2010 Dec;115(6):1508-19. doi: 10.1111/j.1471-4159.2010.07057.x. Epub 2010 Nov 11.

3.

Caspase-independent component of retinal ganglion cell death, in vitro.

Tezel G, Yang X.

Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4049-59.

PMID:
15505055
4.

Redox proteins thioredoxin 1 and thioredoxin 2 support retinal ganglion cell survival in experimental glaucoma.

Munemasa Y, Ahn JH, Kwong JM, Caprioli J, Piri N.

Gene Ther. 2009 Jan;16(1):17-25. doi: 10.1038/gt.2008.126. Epub 2008 Aug 14.

PMID:
18701913
5.

Protective effect of thioredoxins 1 and 2 in retinal ganglion cells after optic nerve transection and oxidative stress.

Munemasa Y, Kim SH, Ahn JH, Kwong JM, Caprioli J, Piri N.

Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3535-43. doi: 10.1167/iovs.08-1716. Epub 2008 Apr 25.

PMID:
18441302
6.

Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma.

Martin KR, Quigley HA, Valenta D, Kielczewski J, Pease ME.

Exp Eye Res. 2006 Aug;83(2):255-62. Epub 2006 Mar 20.

PMID:
16546168
7.

Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma.

Pease ME, McKinnon SJ, Quigley HA, Kerrigan-Baumrind LA, Zack DJ.

Invest Ophthalmol Vis Sci. 2000 Mar;41(3):764-74.

PMID:
10711692
8.

Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model.

Martin KR, Quigley HA, Zack DJ, Levkovitch-Verbin H, Kielczewski J, Valenta D, Baumrind L, Pease ME, Klein RL, Hauswirth WW.

Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4357-65.

PMID:
14507880
9.

Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model.

Mittag TW, Danias J, Pohorenec G, Yuan HM, Burakgazi E, Chalmers-Redman R, Podos SM, Tatton WG.

Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3451-9.

PMID:
11006238
10.
11.

The dark phase intraocular pressure elevation and retinal ganglion cell degeneration in a rat model of experimental glaucoma.

Kwong JM, Vo N, Quan A, Nam M, Kyung H, Yu F, Piri N, Caprioli J.

Exp Eye Res. 2013 Jul;112:21-8. doi: 10.1016/j.exer.2013.04.008. Epub 2013 Apr 18.

12.

Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.

Hains BC, Waxman SG.

Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4164-9.

PMID:
16249495
13.

Axonal protection by Nmnat3 overexpression with involvement of autophagy in optic nerve degeneration.

Kitaoka Y, Munemasa Y, Kojima K, Hirano A, Ueno S, Takagi H.

Cell Death Dis. 2013 Oct 17;4:e860. doi: 10.1038/cddis.2013.391.

14.

Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.

Bosco A, Inman DM, Steele MR, Wu G, Soto I, Marsh-Armstrong N, Hubbard WC, Calkins DJ, Horner PJ, Vetter ML.

Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1437-46. doi: 10.1167/iovs.07-1337.

PMID:
18385061
15.

Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma.

Roh M, Zhang Y, Murakami Y, Thanos A, Lee SC, Vavvas DG, Benowitz LI, Miller JW.

PLoS One. 2012;7(7):e40065. doi: 10.1371/journal.pone.0040065. Epub 2012 Jul 3.

16.

Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix.

Guo L, Moss SE, Alexander RA, Ali RR, Fitzke FW, Cordeiro MF.

Invest Ophthalmol Vis Sci. 2005 Jan;46(1):175-82.

17.

DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.

Kim KY, Perkins GA, Shim MS, Bushong E, Alcasid N, Ju S, Ellisman MH, Weinreb RN, Ju WK.

Cell Death Dis. 2015 Aug 6;6:e1839. doi: 10.1038/cddis.2015.180.

18.

Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage.

Liu Q, Ju WK, Crowston JG, Xie F, Perry G, Smith MA, Lindsey JD, Weinreb RN.

Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4580-9.

PMID:
17898281
19.

Intrinsic axonal degeneration pathways are critical for glaucomatous damage.

Howell GR, Soto I, Libby RT, John SW.

Exp Neurol. 2013 Aug;246:54-61. doi: 10.1016/j.expneurol.2012.01.014. Epub 2012 Jan 18. Review.

20.

Thioredoxins 1 and 2 protect retinal ganglion cells from pharmacologically induced oxidative stress, optic nerve transection and ocular hypertension.

Munemasa Y, Kwong JM, Kim SH, Ahn JH, Caprioli J, Piri N.

Adv Exp Med Biol. 2010;664:355-63. doi: 10.1007/978-1-4419-1399-9_41.

PMID:
20238036
Items per page

Supplemental Content

Write to the Help Desk